Cargando…
iTRAQ-based proteomic analysis of plasma reveals abnormalities in lipid metabolism proteins in chronic kidney disease-related atherosclerosis
Patients with chronic kidney disease (CKD) have a considerably higher risk of death due to cardiovascular causes. Using an iTRAQ MS/MS approach, we investigated the alterations in plasma protein accumulation in patients with CKD and classical cardiovascular disease (CVD) without CKD. The proteomic a...
Autores principales: | Luczak, Magdalena, Formanowicz, Dorota, Marczak, Łukasz, Suszyńska-Zajczyk, Joanna, Pawliczak, Elżbieta, Wanic-Kossowska, Maria, Stobiecki, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013279/ https://www.ncbi.nlm.nih.gov/pubmed/27600335 http://dx.doi.org/10.1038/srep32511 |
Ejemplares similares
-
Label-Free Quantitative Proteomics Reveals Differences in Molecular Mechanism of Atherosclerosis Related and Non-Related to Chronic Kidney Disease
por: Luczak, Magdalena, et al.
Publicado: (2016) -
Deeper insight into chronic kidney disease-related atherosclerosis: comparative proteomic studies of blood plasma using 2DE and mass spectrometry
por: Luczak, Magdalena, et al.
Publicado: (2015) -
Chronic kidney disease-related atherosclerosis - proteomic studies of blood plasma
por: Luczak, Magdalena, et al.
Publicado: (2011) -
Optimization of Plasma Sample Pretreatment for Quantitative Analysis Using iTRAQ Labeling and LC-MALDI-TOF/TOF
por: Luczak, Magdalena, et al.
Publicado: (2014) -
Usefulness of serum interleukin-18 in predicting cardiovascular mortality in patients with chronic kidney disease – systems and clinical approach
por: Formanowicz, Dorota, et al.
Publicado: (2015)